As expected, pharmacological inhibition of the JNK pathway leads to a decrease in proliferation of non-H3.3K27M tumor cells, but remarkably, H3.3K27M cells are affected significantly more (Fig. 6). The gene discussed is MAPK8; the disease is neoplasm.